Curium Lantheus Merger | Lucid Diligence Brief
Curium’s proposed acquisition of Lantheus reshapes the radiopharmaceutical…
Genprex Roche Diagnostics TROP2 Collaboration | Lucid Diligence Brief
Genprex and Roche Diagnostics begin TROP2 assay validation to support…
Roche Ivy Tech Laboratory Workforce Partnership | Lucid Diligence Brief
Roche Diagnostics and Ivy Tech launch an Indiana laboratory workforce…
Massive Bio and GELL Partnership | Lucid Diligence Brief
Massive Bio and GELL have launched a strategic partnership to expand AI-enabled…
Harbour BioMed and Sinopharm Innovation Consortium Expands Biologics Strategy | Lucid Diligence Brief
Harbour BioMed partners with Sinopharm to establish an innovation consortium…
Cardiovascular Strategic Roundup | June 25–July 21, 2026
Cardiovascular Strategic Roundup exploring Developments and Competitive Shifts…
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…
AdaptHealth Diabetes Health Divestiture to Cardinal Health | Lucid Diligence Brief
AdaptHealth exits its Diabetes Health business in a $235 million deal as…
Endocrinology Strategic Roundup | June 23–July 20, 2026
Strategic Developments and Competitive Shifts in Endocrinology Coverage Period:…
Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief
Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…
Nucleai-University of Glasgow Partnership Expands Spatial AI Platform | Lucid Diligence Brief
Nucleai broadened its University of Glasgow collaboration to expand academic…
United Therapeutics’ Thymmune acquisition | Lucid Diligence Brief
United Therapeutics adds Thymmune’s iPSC thymic-cell platform to its…